Cervical cancer in young people could be eradicated with a single shot, studies show

Cervical cancer, a disease primarily caused by the Human Papilloma Virus (HPV), remains a major global health concern, especially for women. Globally, over 600,000 women are diagnosed annually, with an estimated 311,000 to 342,000 deaths. The vast majority of these cases, around 99%, are linked to HPV, with strains 16 and 18 being responsible for about 75% of global cases.

Despite its mortality rate, cervical cancer is nearly entirely preventable through vaccination and regular screening. Recognizing this, the World Health Organization (WHO) has set an ambitious goal to eliminate cervical cancer as a public health problem by 2030. This strategy relies on three pillars: vaccination, screening, and treatment, with a target of 90% of girls being fully vaccinated against HPV by age 15.

Recent studies offer encouraging evidence for the effectiveness of HPV vaccination. Research from Queen Mary University in London indicates that vaccinating girls against HPV at ages 12-13 significantly reduces the incidence of early-stage cervical cancer. The study found that these vaccinated individuals have virtually zero risk of developing cervical cancer by the age of 30.

"It's incredible to think how a single injection can almost eliminate a type of cancer," stated Peter Sasieni, the lead researcher from Queen Mary University, in comments to the BBC. This marks the first study to officially demonstrate the HPV vaccine's efficacy in reducing deaths, with observations made between 2020 and 2024 among young women in England who received the vaccine since 2008.

While global efforts progress, Romania stands out with the highest incidence and mortality rates of cervical cancer in the European Union. This stark contrast highlights the critical need for widespread vaccination and screening programs to combat the disease effectively.

“

It's incredible to think how a single injection can almost eliminate a type of cancer.